About Ardelyx
Ardelyx is a company based in Fremont (United States) founded in 2007 by Peter G Schultz.. Ardelyx has raised $61.1 million across 8 funding rounds from investors including Western Alliance Bank, RA Capital and SLR Investment Corp. The company has 395 employees as of December 31, 2024. Ardelyx operates in a competitive market with competitors including Ironwood Pharma, RedHill Biopharma, DermBiont, Cosmo Pharmaceuticals and Alcresta, among others.
- Headquarter Fremont, United States
- Employees 395 as on 31 Dec, 2024
- Founders Peter G Schultz
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ardelyx, Inc.
-
Annual Revenue
$333.62 M168.06as on Dec 31, 2024
-
Net Profit
$-39.14 M40.76as on Dec 31, 2024
-
EBITDA
$-25.89 M58.24as on Dec 31, 2024
-
Total Equity Funding
$61.1 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
Western Alliance Bank
& 10 more
-
Employee Count
395
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ardelyx
Ardelyx is a publicly listed company on the NASDAQ with ticker symbol ARDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Leadership Team
37 people
Sales and Marketing
8 people
Human Resources and Administration
7 people
Legal and Compliance
6 people
Operations Team
6 people
Software Development Team
4 people
Finance and Accounting
3 people
Product Management Team
2 people
Unlock access to complete
Funding Insights of Ardelyx
Ardelyx has successfully raised a total of $61.1M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(01 Jun 2008)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Post-IPO - Ardelyx | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Ardelyx | Valuation |
investors |
|
| May, 2018 | Amount | Debt – Conventional - Ardelyx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ardelyx
Ardelyx has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Western Alliance Bank, RA Capital and SLR Investment Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare royalty investments are focused on US and UK markets.
|
Founded Year | Domain | Location | |
|
Debt and equity investments are offered by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ardelyx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ardelyx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ardelyx Comparisons
Competitors of Ardelyx
Ardelyx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, RedHill Biopharma, DermBiont, Cosmo Pharmaceuticals and Alcresta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ardelyx
Frequently Asked Questions about Ardelyx
When was Ardelyx founded?
Ardelyx was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Ardelyx located?
Ardelyx is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Who is the current CEO of Ardelyx?
Mike Raab is the current CEO of Ardelyx.
Is Ardelyx a funded company?
Ardelyx is a funded company, having raised a total of $61.1M across 8 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $50M, raised on Jun 01, 2008.
How many employees does Ardelyx have?
As of Dec 31, 2024, the latest employee count at Ardelyx is 395.
What is the annual revenue of Ardelyx?
Annual revenue of Ardelyx is $333.62M as on Dec 31, 2024.
What does Ardelyx do?
Ardelyx was founded in 2007 and is based in Fremont, United States. Focus is placed on developing therapeutics targeting the gastrointestinal tract for conditions including cardio-renal, GI, and metabolic diseases. The lead product, Tenapanor, is advanced as a sodium transport inhibitor for irritable bowel syndrome with constipation and hyperphosphatemia in dialysis patients. Additional efforts involve RDX002 for hyperkalemia treatment in kidney and heart disease patients.
Who are the top competitors of Ardelyx?
Ardelyx's top competitors include Ironwood Pharma, RedHill Biopharma and Inozyme Pharma.
Is Ardelyx publicly traded?
Yes, Ardelyx is publicly traded on NASDAQ under the ticker symbol ARDX.
Who are Ardelyx's investors?
Ardelyx has 11 investors. Key investors include Western Alliance Bank, RA Capital, SLR Investment Corp, Kyowa Kirin, and HealthCare Royalty Partners.
What is Ardelyx's ticker symbol?
The ticker symbol of Ardelyx is ARDX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.